Table 2.
No. | Author and year | Age | Sample size | No. of Turicella otitidis cases or percentage | Condition | Source of isolation | Identification | ||
---|---|---|---|---|---|---|---|---|---|
1 | Gavrilovici, C., et al., 2022 [9] | 2 months-7 years | 147 | n = 1 | Acute otitis media | Pus | MICROSCAN panels (PC42, HIND) and MALDI-TOF MS | NA | |
2 | Mendez-Legaza, J.M., et al.,2021 [23] | 0–14 years and 2–81 years | 1089 samples | n = 22 | ear exudate | External auditory canal | Culture, API Coryne, MALDI-TOF MS | ||
3 | Chen, T.Y., et al. 2021 [20] | NS | 107 culturable isolates | n = 10 | Otitis media | Middle ear sample | NS | ||
4 | Álvarez, A.S. and M.G. Coca, 2021 [32] | NS | 273 ear exudates | n = 18 | Acute otitis media | Middle ear fluid samples | ANC card of the Vitek2® system | ||
5 | Barron, C.L., et al., 2020 [19] | 9 months- 19 years | 38 effusion | n = 1 | Chronic middle ear effusions | Middle ear fluid | Culture, Immunoblot (DNABII proteins) | ||
6 | Ari O., et al., 2019 [15] | NS | 25 children | 6% | Otitis media with effusion | Ear | 16 S rRNA metagenomics | ||
7 | Man, W.H., et al., 2019 [28] | > 5 years | 94 children | n = 5 | Acute otitis media | Tympanostomy tube otorrhea | 16 S ribosomal RNA-based sequencing | ||
8 | Kolbe, A.R., et al., 2019 [10] | 3-176 months | 50 children | n = 26 | Chronic otitis media | Middle ear fluid | DNA sequencing | ||
9 | Kalcioglu, et al., 2018 [24] | NS | 102 samples | n = 5/26 (cholesteatomy), n = 4/18 (typanosclerotic plaque | Chronic otitis media | Middle ear | PCR, 16 ribosomal RNA | ||
10 | Sillanpää, S., et al., 2017 [42] | 5–42 months | 79 | n = 5 | Acute otitis media | Middle ear fluid samples | Nested-PCR amplification of the 16 S rRNA gene (V4 region), mass sequencing | ||
11 | Vila, P.M., et al., 2017 [22] | 2–6 years | 54 | n = 4 | Otitis media (cochlear implant) | Middle ear | Culture | ||
12 | Krueger, A., et al., 2017 [27] | 0–24 months (n = 25), > 24 month (n = 30) | 55 | 7.84% | Middle ear effusion | Middle ear | Western blot and DNA and molecular analysis | ||
13 | Quesnel, S., et al., 2010 [8] | 3 months-15 years | 188 | n = 4 | Acute mastoiditis | Drainage of retro auricular abscess, paracentesis | Culture | ||
14 | Jeziorski, E., et al.2009 [21] | NS | 12 | n = 12 | Acute otitis media, acute pyelonephritis, seromucous otitis, acute myeloid leukemia, acute lymphoid leukemia | Middle ear | Stain, culture, DNAse, CAMP test | ||
15 | Gomez-Garces, J.L., et al., 2004 [43] | 6 months-7 years | 153 ear exudates (112 patients) | n = 7 | Acute exudative otitis media or exacerbation of chronic otitis media | Middle ear | API Coryne, API Zym, API 50 CH, morphological and phenotypic tests | ||
16 | Holzmann, D., et al., 2002 [30] | NS | 60 children | n = 14 | Exudative otitis media | Middle ear effusion | Culture, biochemical and chemotaxonomic data | ||
17 | Funke, G., et al., 1994 [39] | 1–5 years | NS | NS | Otitis media | Middle ear fluid | Biochemical, API Coryne, and 16 S rRNA sequencing |
NS Not specified, PCR Polymerase chain reaction